Flebitis zero project identifies infusion phlebitis rate

“The incidence density of phlebitis, during the period from 2017 to 2021, was 1.82 cases of phlebitis per 100 venous catheter-days” Cernuda Martínez et al (2023).
Peripheral IV catheter depth and thrombophlebitis – Full Text

“In our treatment center, while appropriate fixation was ensured, the catheter indwelling depth shall be as short as possible, so as to reduce the occurrence of thrombophlebitis” He et al (2023).
Potassium chloride-induced phlebitis due to malpositioned CVC – Full Text

“We present a case of potassium chloride-induced phlebitis with severe, burning, left-sided chest pain when infused via a malpositioned central venous catheter” Camp et al (2023).
Chemotherapy induced infusion phlebitis

“Peripheral epirubicin administration will result in severe CIP being experienced by a proportion of patients irrespective of whether infusion pump or manual injection method is used” Williams et al (2023).
Infusion-related phlebitis reduction

“Here we review the major etiologies of IRP and describe potential pharmacological and nonpharmacological interventions for preventing and managing the condition as well as for improving vascular access health in multiple-drug administration settings” Johnson et al (2023).
Biofilm-associated candidal PICC infection – Full Text

“Blood culture detected Candida albicans and plain computed tomography (CT) revealed gas production surrounding the catheter in the brachiocephalic vein (Fig. 1a), leading to a diagnosis of central line-associated candidemia” Fukushima et al (2023).
Chemotherapy infusion phlebitis study

“Platinum and cyclophosphamide are commonly associated with phlebitis which can be managed by topical heparin plus benzyl nicotinate. Phlebitis shouldn’t be ignored as it has a high incidence, affects the quality of life, and increases the treatment burden” Sudhakar et al (2023).
Amiodarone-induced phlebitis – Full Text

“A large proportion of the patients developed amiodarone-induced phlebitis. The adherence to the clinical practice guideline was not optimal according to the PIVC recommendations” Brørs et al (2023).
Infusion phlebitis risk factors – Full Text

“We investigated the risk factors for peripheral phlebitis according to BMI in ICU and observed different risk factors in groups stratified by BMI” Kashiura et al (2022).
Topical treatment of infusion phlebitis – Full Text

“To systematically evaluate the efficacy of different topical treatments for PVC-related phlebitis in hospital in-patients” Garcia-Expósito et al (2022).
Peripheral IV phlebitis risk factors – Full Text

“Risk factors for phlebitis involved intrinsic and extrinsic factors to the patient, indicating preventive nursing interventions such as promoting patient mobility, not catheterizing veins in the dorsal arch of the hand, cautious infusion of risk drugs, and valuing pain complaints” Simões et al (2022).
Infusion phlebitis patient questionnaire

“The study depicted high prevalence of phlebitis factored in by poor vein assessment and increase in indwelling time” Nikhila et al (2022).